# SAB Biotherapeutics, Inc.: Form SCHEDULE 13D, filed Oct 3, 2025

- Company: [SAB Biotherapeutics, Inc.](/companies/sabs.md) (CIK 1833214)
- Form: SCHEDULE 13D
- Filed: 2025-10-03
- Accepted by EDGAR: Oct 3, 2025, 16:26 ET
- Period: not reported
- Accession: 0001346824-25-000015
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1833214/000134682425000015/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1833214/000134682425000015/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1833214/000134682425000015/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001346824-25-000015. Last ingested by Listed: Nov 5, 2026, 12:06 ET. No prices; not investment advice.
